Sedona Sweeney
banner
sedonasweeney.bsky.social
Sedona Sweeney
@sedonasweeney.bsky.social
Associate Professor of Health Economics @ LSHTM, focusing on patient and provider costs of long-term health shocks incl TB & HIV. Edinburgh-based.
Reposted by Sedona Sweeney
Today 15.00 'The Cost of Treating Tuberculosis' the first in a series of 3 webinars focused on topics related to health economics and TB, hosted by ERA4TB, the National Institute for Health and Care Excellence (NICE) and COMBINE.
Register forms.biocom.de/index.php/68...
@sedonasweeney.bsky.social
April 9, 2025 at 9:01 AM
Reposted by Sedona Sweeney
🌍 🏦 Tomorrow @sedonasweeney.bsky.social will give a webinar with @era4tb.bsky.social & @amr-accelerator.bsky.social on TB’s global cost burden to people and health systems, and how health economics can help direct priorities for developing new TB treatments

Join 👇
amr-accelerator.eu/event/combin...
COMBINE-ERA4TB Webinar on The Cost of Treating Tuberculosis - IMI AMR Accelerator
The cost of treating tuberculosis – the role of health economics in TB treatment development Join us for this webinar with health economics experts to examine TB’s global cost burden […]
amr-accelerator.eu
April 8, 2025 at 12:01 PM
Reposted by Sedona Sweeney
💊 On #WorldTBDay, we wanted to highlight just one example of our Centre’s work on tuberculosis

A recent paper from @sedonasweeney.bsky.social found how the BPal multi-antibiotic regimen was the most cost-effective treatment for rifampicin-resistant #TB

Read more 🔽
www.lshtm.ac.uk/research/cen...
March 24, 2025 at 12:51 PM
Reposted by Sedona Sweeney
Closing today… open to US scientists, just saying…

Come join an interdisciplinary team looking #AMR dynamics from multiple angles!
The deadline for this is Friday! do get in touch if you have any questions.
The advert is now live here:
jobs.lshtm.ac.uk/EPH-EPED-202...

Until August 2027 we would be working on data analysis and modelling to try and untangle the dynamics of #AMR by age and sex exploring electronic health records 🧫📑👩‍💻. Get in touch if any questions!
February 14, 2025 at 2:19 PM
Reposted by Sedona Sweeney
Good morning to this man, and this man only #bbcqt
February 14, 2025 at 8:04 AM
Reposted by Sedona Sweeney
A bright light in a dark moment: The price of the critical TB drug bedaquiline has now dropped to $90 per adult treatment course for TB, a 54% reduction since just 2023.

This is a huge win for @tbfighters.org and the TB activism community generally. www.stoptb.org/what-we-do/f... (1/2)...
Access bedaquiline | StopTB Partnership
www.stoptb.org
February 7, 2025 at 3:01 PM
Reposted by Sedona Sweeney
Just received this photo from a friend of a warehouse in Kinshasa. These are tuberculosis medications--ALREADY PAID FOR--that aren't being distributed due to the Trump Administration's stop work order.
TB treatment is being interrupted in SO many patients around the world. What does that mean? (1/2)
February 7, 2025 at 5:18 PM
Reposted by Sedona Sweeney
The deadline for this is Friday! do get in touch if you have any questions.
The advert is now live here:
jobs.lshtm.ac.uk/EPH-EPED-202...

Until August 2027 we would be working on data analysis and modelling to try and untangle the dynamics of #AMR by age and sex exploring electronic health records 🧫📑👩‍💻. Get in touch if any questions!
February 11, 2025 at 9:37 AM
Reposted by Sedona Sweeney
#Tuberculosis: We conducted the first within-trial cost-utility analysis of 6-month BPaL-based regimens (bedaquiline, pretomanid, and linezolid) for rifampin-resistant #TB.

More about our findings below ⬇️ #IDSky #AidSky #MedSky
February 7, 2025 at 7:58 PM
Reposted by Sedona Sweeney
On Tuesday 11 Feb, join us for an amazing symposium, free and open to all. No registration required
tinyurl.com/335xhj29
Person-centred care for tuberculosis affected households | LSHTM
Tuberculosis-affected households have syndemic vulnerability, reflecting a concentration of and interactions between multiple biomedical, psychosocial, and structural determinants of health.
tinyurl.com
February 5, 2025 at 4:17 PM
Reposted by Sedona Sweeney
PhD opportunity @lshtm-tbmod.bsky.social modelling intersection of TB (world #1 infectious killer) & climate change. Do apply to be part of a great group doing impactful work! www.lshtm.ac.uk/study/fees-a... @lshtm.bsky.social @cmmid-lshtm.bsky.social @reinhouben.bsky.social @laragosce.bsky.social
2025-26 UKHSA-LSHTM PhD Scholarship | LSHTM
The London School of Hygiene and Tropical Medicine (LSHTM) is pleased to invite applications for a 3-year full-time PhD studentship, starting in September 2025, held between the Faculty of
www.lshtm.ac.uk
February 5, 2025 at 9:12 AM
Reposted by Sedona Sweeney
What’s his beef against USAID in particu….oh. Wow.
February 3, 2025 at 11:19 AM
Reposted by Sedona Sweeney
USAID being unlawfully dismantled. DOGE member has closed HQ. New tranche of workers cut off email.

Staff tell me, "It is frightening being inside USAID right now. Our checks and balances failed. Congress has abdicated its responsibilities.”

And Sec. Rubio has abdicated his.
New — USAID staff received an email just a few minutes ago letting them know HQ would be closed to all personnel Monday. It’s likely some employees will miss the overnight email, show up and be turned away.

It was sent by Gavin Kliger, one of the young guys at DOGE doing Musk’s bidding.
February 3, 2025 at 12:57 PM
Reposted by Sedona Sweeney
BPaL/M is cost saving based on our in-trial economic evaluation of TB-Practecal, supporting modelling studies. Great collaboration with Dr Sedona Sweeney @lshtm.bsky.social and @msfsci.bsky.social.

www.thelancet.com/journals/lan...

#TBsky #IDsky
24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluation
This trial-based evidence adds to consistent indications from modelling studies that BPaL-based regimens are cost-saving for both the patient and health system. Urgent implementation of BPaL-based reg...
www.thelancet.com
January 30, 2025 at 8:51 PM
Amazing timing that this paper has come out just as I return to work from maternity leave! Very proud of the work that went into this, and glad it is finally out.

www.sciencedirect.com/science/arti...
24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluation
New 6-month rifampicin-resistant tuberculosis treatment regimens containing bedaquiline, pretomanid, and linezolid (BPaL) with or without moxifloxacin…
www.sciencedirect.com
January 30, 2025 at 9:25 PM
Reposted by Sedona Sweeney
🎉 Bringing you our new Bluesky account all the way from Windsor

While we’re enjoying our retreat, why don’t you follow the new #GHECO account? It's the perfect place to get all the latest health economics news & updates in @lshtm.bsky.social
January 29, 2025 at 3:41 PM